,
Early detection for breast cancer changes the game, so let's kick off a new era of breast health.
Busy right now? We got you. Sign up for a reminder to put your breasts first.
Give breasts the attention they actually deserve.
We pay so much attention to breasts yet 1 in 2 women don't get their annual breast screenings* that can catch cancer early, when it's most treatable.
Since everyone’s breast cancer risk is unique, here’s a quick break down. If you’re 40 and over, make annual screening a priority. If you’re under 40, now’s the time to find out your breast cancer risk and discuss with your doctor whether you should start screening earlier.
Get Screened
If you’re 40 and over, schedule time with your doctor or find a place near you to get screened.
.
Understand Your Risk
If you're under 40, answer a few questions to understand your potential risk of getting breast cancer — trust us, it’s worth it.
.
´
Give me the deets.
Together with Susan G. Komen, NOVARTIS helped create the Alliance for Breast Cancer Policy, bringing together 25+ like-minded partners to improve outcomes in breast cancer through policy changes—moving from attention to action. The coalition's first priority is passing the Access to Breast Cancer Diagnosis (ABCD) Act—a crucial first step toward breaking down barriers to early detection and diagnosis.
Mammograms may not tell the whole story. For instance, if you are at a high risk, you might need an MRI or ultrasound, too—additional exams that usually aren’t fully covered by insurance, translating into high out-of-pocket costs.
The goal of the ABCD Act is to take steps to eliminate cost barriers for these additional breast cancer screenings and follow-up diagnostic imaging, avoiding delays in diagnosis.
Get involved.
Show your support by sending a letter to your federal representatives, and learn more about the Alliance.
Working together to change the numbers.
Learn more about how NOVARTIS is working with our incredible partners to offer support, provide resources, and answer any questions you might have about breast cancer.
Congrats!
You're one step closer to prioritizing your breast health! Now, spread the word by visiting us on social—and get your crew to sign up, too.
Spread the word.
Check us out on social and share with the mothers, sisters, and loves in your life — we all need a reminder that our breast health matters.
You have our attention.
Addressing this devastating disease requires a broad, collaborative approach. At Novartis, we’ve spent 30+ years advancing science and are committed to inspiring meaningful change that goes beyond medicine. With organizations like Susan G. Komen, TOUCH (The Black Breast Cancer Alliance), Living Beyond Breast Cancer, BreastCancer.org, and other leaders by our side, Novartis is reimagining medicine to save lives and create lasting impact against breast cancer.
Helping you navigate testing and treatment options based on your breast cancer.
Helping you move forward with a diagnosis of early breast cancer.
Staying hopeful with a diagnosis of metastatic breast cancer.
* Estimates include women aged ≥ 40 between 2017-2021.
† According to the latest data, nearly 100% of people live at least 5 years when cancer is detected early and in the localized stage.
† According to the latest data, nearly 100% of people live at least 5 years when cancer is detected early and in the localized stage.